doi:10.3969/j.issn.1673-8640.2016.011.012

Abstract

CLC Number:

R446.1

Figures/Tables 3

References 11

1	徐群飞,刘淑媛,张世锟,等. 血液分析仪显微镜镜检规则的建立与验证[J]. 实验与检验医学,2013,31(6):566-567.
2	陆进,金燕,吴元健. Sysmex XE-5000血液分析仪检测非血体液细胞的性能评价[J]. 临床检验杂志,2012,30(4):318-319.
3	胡晓波,姚怡婷,王青,等. 2014版ICSH体液细胞自动计数仪性能和验证指南介绍[J]. 检验医学,2015,30(3):209-213.
4	龚彩平,罗燕飞,范小斌,等. XE-5000血液分析仪对穿刺液常规的应用评价[J]. 中国误诊学杂志,2011,11(4):866-867.
5	罗丽贞,刘春林,吴清念,等. Sysmex XE-5000血液分析仪体液模式筛查肿瘤细胞价值的评价[J]. 检验医学,2014,29(2):169-171.
6	叶应妩,王毓三,申子瑜. 全国临床操作规程[M]. 3版. 南京:东南大学出版社,2006:58.
7	刘成玉,罗春丽. 临床检验基础[M]. 5版. 北京:人民卫生出版社,2012:224-227.
8	梁华兵,卢兴国. 胸腹水癌细胞形态学检验诊断的实践与体会[J]. 检验医学,2013,28(6):557-560.
9	彭明婷. 血液分析仪质量控制的问题与对策[J]. 检验医学,2008,23(6):551-553.
10	何银华,颜宇飞,蔡峥,等. Sysmex XE-2100全自动血液分析仪计数胸腹水有核细胞的评价[J]. 检验医学,2011,26(4):228-230.
11	许秀妆,陈燕妆,章金灿,等. Sysmex XE-5000全自动血细胞分析仪性能评价[J]. 检验医学与临床,2011,8(23):2896-2898.

组别	例数	手工法	SYSMEX XN-2000	r值	p值
A组	18	70.22±44.79	68.67±48.60	0.983	0.488
B组	27	506.19±187.95	499.41±192.93	0.993	0.542
C组	31	8 382.58±31 144.60	8 349.45±31 356.12	0.998	0.273

组别	例数	手工法	SYSMEX XN-2000	r值	p值
A组	18	70.22±44.79	68.67±48.60	0.983	0.488
B组	27	506.19±187.95	499.41±192.93	0.993	0.542
C组	31	8 382.58±31 144.60	8 349.45±31 356.12	0.998	0.273

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 11

Related Articles 15

Recommended Articles

Metrics